Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants | MicrobiomeTrials← Back to trialsNCT07249320
Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-12-01Est. Completion: 2027-09-30
Enrollment target: 1 participants Locations- Pfizer, New York, New York, United States
Other microbiome trials you might be interested in
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, SpainEst. completion Oct 2, 2026
Acute Respiratory Infections (ARIs)
This is a prospective, observational, multicenter study employing continuous, convenience sampling, stratified by study …
Ho Chi Minh City, Vietnam
Est. completion Jun 4, 2028